Acumen Pharmaceuticals (ABOS) Short Interest Ratio & Short Volume → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free ABOS Stock Alerts $3.40 +0.04 (+1.19%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Acumen Pharmaceuticals Short Interest DataCurrent Short Volume1,050,000 sharesPrevious Short Volume1,240,000 sharesChange Vs. Previous Month-15.32%Dollar Volume Sold Short$3.71 millionShort Interest Ratio / Days to Cover3.1Last Record DateApril 15, 2024Outstanding Shares60,080,000 sharesFloat Size43,660,000 sharesShort Percent of Float2.40%Today's Trading Volume149,899 sharesAverage Trading Volume355,901 sharesToday's Volume Vs. Average42% Short Selling Acumen Pharmaceuticals ? Sign up to receive the latest short interest report for Acumen Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatABOS Short Interest Over TimeABOS Days to Cover Over TimeABOS Percentage of Float Shorted Over Time Ad Crypto 101 MediaElon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. Acumen Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,050,000 shares $3.71 million -15.3%2.4%3.1 $3.53 3/31/20241,240,000 shares $5.02 million +21.6%2.9%3.4 $4.05 3/15/20241,020,000 shares $4.26 million +31.9%2.5%2.5 $4.18 2/29/2024773,400 shares $3.33 million +13.8%1.9%1.8 $4.31 2/15/2024679,700 shares $2.13 million -7.2%1.6%1.6 $3.13 1/31/2024732,100 shares $2.33 million +4.7%1.9%1.5 $3.18 Get the Latest News and Ratings for ABOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acumen Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024699,400 shares $2.71 million +53.7%1.8%1.3 $3.88 12/31/2023455,200 shares $1.75 million -25.3%1.1%0.8 $3.84 12/15/2023609,600 shares $1.76 million +13.3%1.5%1.2 $2.88 11/30/2023538,300 shares $1.29 million +3.6%1.3%1.1 $2.40 11/15/2023519,500 shares $1.23 million -35.1%1.3%1.1 $2.37 10/31/2023800,000 shares $1.50 million -60.8%1.8%1.8 $1.87 10/15/20232,040,000 shares $7.63 million -1.0%4.6%4.6 $3.74 9/30/20232,060,000 shares $8.55 million +17.1%4.7%1.8 $4.15 9/15/20231,760,000 shares $9.73 million +0.6%4.0%1.6 $5.53 8/31/20231,750,000 shares $10.54 million +8.0%4.0%1.6 $6.02 8/15/20231,620,000 shares $11.53 million +4.5%3.7%1.5 $7.12 7/31/20231,550,000 shares $11.47 million +154.0%3.5%1.5 $7.40 7/15/2023610,200 shares $3.83 million +218.8%1.6%0.6 $6.28 6/30/2023191,400 shares $920,634.00 +26.8%0.7%0.7 $4.81 6/15/2023151,000 shares $847,110.00 -37.1%0.5%0.8 $5.61 5/31/2023240,200 shares $1.18 million +50.3%0.9%1.3 $4.93 5/15/2023159,800 shares $990,760.00 -26.3%0.6%0.9 $6.20 4/30/2023216,800 shares $836,848.00 -63.2%0.8%1.5 $3.86 4/15/2023589,700 shares $2.21 million -1.5%2.1%5.9 $3.74 3/31/2023598,400 shares $2.43 million -3.2%2.2%6.5 $4.06 3/15/2023618,000 shares $2.54 million -2.5%2.2%7.6 $4.11 2/28/2023634,100 shares $3.34 million +6.2%2.3%7.8 $5.27 2/15/2023597,000 shares $3.36 million -2.1%2.2%6.7 $5.62 1/31/2023609,900 shares $4.01 million +1.0%2.0%6 $6.57 1/15/2023603,600 shares $3.77 million +5.6%2.1%5.4 $6.24 12/30/2022571,700 shares $3.09 million -34.7%2.0%4 $5.40 12/15/2022875,700 shares $4.61 million +24.3%3.5%0.6 $5.27 11/30/2022704,700 shares $4.00 million -9.1%2.9%0.5 $5.68 11/15/2022775,600 shares $5.00 million -24.0%3.1%0.6 $6.45 10/31/20221,020,000 shares $7.06 million -23.3%4.2%0.8 $6.92 10/15/20221,330,000 shares $10.52 million -43.6%5.5%1 $7.91 9/30/20222,360,000 shares $23.67 million +238.1%9.7%1.8 $10.03 9/15/2022698,000 shares $4.31 million -0.3%2.9%6.2 $6.18 8/31/2022700,200 shares $3.98 million -32.0%2.9%5.1 $5.69Exposed: 10 CENT Crypto to Explode May 20th? (Ad)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 ABOS Short Interest - Frequently Asked Questions What is Acumen Pharmaceuticals' current short interest? Short interest is the volume of Acumen Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 1,050,000 shares of ABOS short. 2.40% of Acumen Pharmaceuticals' shares are currently sold short. Learn More on Acumen Pharmaceuticals' current short interest. What is a good short interest ratio for Acumen Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABOS shares currently have a short interest ratio of 3.0. Learn More on Acumen Pharmaceuticals's short interest ratio. Which institutional investors are shorting Acumen Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Acumen Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Acumen Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.40% of Acumen Pharmaceuticals' floating shares are currently sold short. Is Acumen Pharmaceuticals' short interest increasing or decreasing? Acumen Pharmaceuticals saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 1,050,000 shares, a drop of 15.3% from the previous total of 1,240,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Acumen Pharmaceuticals' float size? Acumen Pharmaceuticals currently has issued a total of 60,080,000 shares. Some of Acumen Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acumen Pharmaceuticals currently has a public float of 43,660,000 shares. How does Acumen Pharmaceuticals' short interest compare to its competitors? 2.40% of Acumen Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Acumen Pharmaceuticals: Cardiff Oncology, Inc. (8.92%), Compass Therapeutics, Inc. (1.88%), Century Therapeutics, Inc. (6.91%), X4 Pharmaceuticals, Inc. (7.30%), Innate Pharma S.A. (0.10%), Opthea Limited (0.21%), Adverum Biotechnologies, Inc. (7.54%), Zura Bio Limited (2.27%), Candel Therapeutics, Inc. (12.96%), Sutro Biopharma, Inc. (3.49%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Acumen Pharmaceuticals stock? Short selling ABOS is an investing strategy that aims to generate trading profit from Acumen Pharmaceuticals as its price is falling. ABOS shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Acumen Pharmaceuticals? A short squeeze for Acumen Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ABOS, which in turn drives the price of the stock up even further. How often is Acumen Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABOS, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: INmune Bio Short Squeeze Zura Bio Short Squeeze Opthea Short Squeeze Kodiak Sciences Short Squeeze Compugen Short Squeeze Ovid Therapeutics Short Squeeze Innate Pharma Short Squeeze Elevation Oncology Short Squeeze Adverum Biotechnologies Short Squeeze Century Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ABOS) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsHow Biden has already won 2024Porter & Company